Emory Cancer Prevention and Control Network to boost lung cancer screening
SIP-24-003 Cancer Prevention and Control Research Network (CPCRN)
This project helps clinics and communities use proven cancer and lung screening approaches so more people who are eligible get screened.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11179100 on NIH RePORTER |
What this research studies
You would see the team working with local clinics and community groups to bring evidence-based cancer prevention and lung cancer screening into regular care. They will review existing screening tools and studies, ask primary care doctors and lung experts about practical ways to determine who should be screened, and run a small pilot with 20 patients at a primary care center in Southwest Georgia to check comprehension, acceptability, and feasibility. The results will be used to design and test an intervention that makes lung cancer screening easier to offer and understand in community clinics. The goal is to increase use of effective screening strategies in communities that need them.
Who could benefit from this research
Good fit: Ideal candidates are adults who meet lung cancer screening criteria (typically older current or former smokers) and patients seen at participating primary care clinics, especially in the Southwest Georgia pilot site.
Not a fit: People who are not at risk for lung cancer (for example younger never-smokers) or those not served by participating clinics are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, more eligible people could get screened earlier, which may catch cancers sooner and reduce illness and deaths.
How similar studies have performed: Other implementation programs have improved uptake of some cancer screenings, but lung cancer screening has unique barriers so this project mixes established strategies with new local testing.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Escoffery, Ngoc-Cam — Emory University
- Study coordinator: Escoffery, Ngoc-Cam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.